comment on this article

Evonetix looks to scale up chip based technology production

The Cambridge company, Evonetix, has announced that it is collaborating with imec to scale-up chip-based technology production of its third generation DNA synthesis platform.

Evonetic is a synthetic biology company that is looking to develop a desktop platform for scalable, high-fidelity and rapid gene synthesis. In partnering with imec, a leading research and
innovation hub active in the fields of nanoelectronics and digital technologies, it is looking to increase production of its proprietary microelectromechanical systems (MEMS)-based silicon chips, enabling the platform to be manufactured at a commercial scale.

The novel silicon chip is a key component of Evonetix’s desktop DNA platform which, once fully developed, will enable the rapidly growing field of synthetic biology.

Evonetix’s technology utilises a silicon chip, made by MEMS processing, that controls the synthesis of DNA at many thousands of independently controlled reaction sites or ‘pixels’ on the chip surface in a highly parallel fashion.

Following synthesis, strands are assembled on-chip into double-stranded DNA in a process that identifies and removes errors, enabling accuracy, scale and speed that is several orders of

magnitude better than conventional approaches.
Under the terms of the collaboration, imec will work with Evonetix to scale up manufacturing of the MEMS technology on 8-inch silicon wafers, enabling Evonetix to supply customers in volume. Imec is able to leverage its experience in manufacturing silicon for life sciences applications to transfer the Evonetix process to their foundries and to manage further expansion in volume.

Commenting Dr Matthew Hayes, Chief Technology Officer at Evonetix, said: “With the support of imec, a world-renowned leader in microchip technology, we will be able to optimise our highly parallel desktop platform for commercial supply.”

Neil Tyler

Comment on this article

This material is protected by MA Business copyright See Terms and Conditions. One-off usage is permitted but bulk copying is not. For multiple copies contact the sales team.

What you think about this article:

Add your comments


Your comments/feedback may be edited prior to publishing. Not all entries will be published.
Please view our Terms and Conditions before leaving a comment.

Related Articles